| 中文名 | 水杨酸拉米呋啶 |
|---|---|
| 英文名 | [(2R,5S)-5-(4-amino-2-oxopyrimidin-1-yl)-1,3-oxathiolan-2-yl]methyl 2-hydroxybenzoate |
| 中文别名 |
拉米夫定水杨酸盐
(2R-顺式)-4-氨基-1-(2-羟甲基-1,3-氧硫杂环戊烷-5-基)-1H-嘧啶-2-酮 2-羟基苯甲酸酯 拉米夫定中间体 CTS ((2R,5S)-5-(4-氨基-2-氧代嘧啶-1(2H)-基)-1,3-氧硫杂环戊烷-2-基)甲基 2-羟基苯甲酸酯 水杨酸拉米夫定 (2R-顺式)-4-氨基-1-[2-羟甲基-1,3-氧硫杂环戊烷-5-基]-1H-嘧啶-2-酮 2-羟基苯甲酸酯(拉米夫定水杨酸盐) 拉米水杨酸 |
| 英文别名 |
(2r-cis)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1h)-pyrimidinone 2-hydroxybenzoate
2-Hydroxybenzoic acid - 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone (1:1) 2r-(Hydroxymethyl)-5(S)-Cytosin-1-Yl-1,3-Oxathiolanesalicycic Acid Salt Benzoic acid, 2-hydroxy-, compd. with 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone (1:1) lamivudine salicylate 2R-(HYDROXYMETHYL)-5(S)-CYTOSIN-1-YL-1,3-OXATHIOLANESALICYCIC ACID SALT (LAMIVUDINE SALICYLATE) ((2R,5S)-5-(4-Amino-2-oxopyriMidin-1(2H)-yl)-1,3-oxathiolan-2-yl)Methyl 2-hydroxybenzoate 2R-(hydroxymethyl)-5(s)-cytosin-1-yl-[1,3]-oxathiolane salicylic acid salt (intermediate of lamivudine) (2R,5S)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- 2-(1H)-pyrimidinone salicylate(Lamivudine Salicylate) 2R-(hydroxymethyl)-5(S)-cytosin-lyl-1,3-oxothiolane salicylic acid salt (Lamivudine Salicylate) 2R-(HYDROXYMETHYL)-5(S)-CYTOSIN-1-YL-[1,3]-OXATHIOLANE SALICYLIC ACID SALT (2R-Cis)-4-Amino-1[2-(Hydroxymethyl)-1,3-Oxathiolan-5-Yl]-2(1H)-PyrimidinoneSalicylateMonohydrate Lamivudine Salicylate (CTS) (2R, 5S) -2-(Hydroxymethyl)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane salicylate |
| 描述 | 拉米夫定(BCH-189)水杨酸盐是一种口服活性核苷逆转录酶抑制剂(NRTI)。水杨酸拉米夫定可以抑制HIV逆转录酶1/2,也可以抑制乙型肝炎病毒的逆转录酶。水杨酸拉米夫定可穿透中枢神经系统[1][2]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C15H17N3O6S |
|---|---|
| 分子量 | 367.377 |
| 精确质量 | 367.083801 |
| PSA | 173.20000 |
| LogP | 1.07750 |
|
~%
173522-96-8 |
| 文献:WO2009/69012 A1, ; Page/Page column 22-23 ; |
|
~%
173522-96-8 |
| 文献:WO2009/69011 A1, ; Page/Page column 17-18 ; |
| 上游产品 3 | |
|---|---|
| 下游产品 1 | |